Top Institutions in Dermatology
Leading academic medical centers with strong dermatology departments and translational immunology research programs typically conduct and lead phase 3 clinical trials involving novel biologics for inflammatory skin diseases. Institutions with expertise in clinical trial design, patient-reported outcome measures, and immunodermatology are central to advancing therapies targeting cytokine pathways such as IL-31.
-
#1
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
NIAID leads extensive research on immunologic mechanisms underlying skin diseases including atopic dermatitis and prurigo nodularis, and has a strong track record in conducting large-scale, multicenter clinical trials of biologics targeting cytokine pathways.
Key Differentiators
- Dermatology
- Immunology
- Clinical Trials
-
#2
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins has a renowned dermatology department with expertise in atopic dermatitis and prurigo nodularis, pioneering research on cytokine signaling and itch mechanisms, and extensive experience in clinical trials of novel dermatologic therapies.
Key Differentiators
- Dermatology
- Immunology
- Clinical Research
-
#3
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
UPenn is a leader in immunodermatology research with significant contributions to understanding cytokine-mediated itch and inflammation, and has participated in multiple phase 3 trials of biologics for atopic dermatitis.
Key Differentiators
- Dermatology
- Immunology
- Clinical Trials
-
#4
Massachusetts General Hospital (MGH) Dermatology
Boston, MA
MGH has a robust dermatology clinical trials unit with expertise in inflammatory skin diseases and pruritus, contributing to research on novel biologics including IL-31 inhibitors.
Key Differentiators
- Dermatology
- Clinical Trials
- Immunology
-
#5
Stanford University School of Medicine
Stanford, CA
Stanford combines cutting-edge immunology research with clinical dermatology expertise, focusing on cytokine biology and novel therapeutic targets for pruritic skin diseases.
Key Differentiators
- Dermatology
- Immunology
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
